Tenax Therapeutics Inc (TENX) - Year-over-year net earnings per share growth for the last 12 months

Brandmark of Tenax Therapeutics, Inc. (TENX)

Quarterly EPS volatility on the GURU.Markets chart demonstrates current trends, where the value 21.80 expresses the state of the metric. Tenax Therapeutics (TENX) is reducing regulatory risks while simultaneously testing drugs for pulmonary arterial hypertension. Christopher Kenyon ensures a rigorous scientific approach to asset advancement. Stable laboratory operations and contractor audits guarantee the uninterrupted creation of compounds.

TENX: tenaxthera.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 11/16/2026

Analytical breakdowns for Tenax Therapeutics

- share price and consensus valuation forecast:
Summary company analytics:Tenax Therapeutics Inc. - TENX
Flagship merchandise of Tenax Therapeutics

Professional capital evaluates Tenax Therapeutics (TENX) through the lens of monetizing its pulmonary hypertension therapy ecosystem, where drug efficacy directly converts into shareholder value. By analyzing quarterly EPS dynamics, the investor observes the actual growth rate of net income per share, which eliminates manipulation and confirms operational resilience, although a sharp shift in market conditions could offset current growth.

Competitor analysis

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|HeartBeam Corporation (BEAT) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)